Patent details
EP3585442 Title: THERAPY OF SMALL-CELL LUNG CANCER (SCLC) WITH A TOPOISOMERASE-I INHIBITING ANTIBODY-DRUG CONJUGATE (ADC) TARGETING TROP-2
Basic Information
- Publication number:
- EP3585442
- PCT Application Number:
- US2018019025
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP187581202
- PCT Publication Number:
- WO2018156634
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- THERAPY OF SMALL-CELL LUNG CANCER (SCLC) WITH A TOPOISOMERASE-I INHIBITING ANTIBODY-DRUG CONJUGATE (ADC) TARGETING TROP-2
- French Title of Invention:
- THÉRAPIE DU CANCER DU POUMON À PETITES CELLULES (CPPC) AVEC UN CONJUGUÉ ANTICORPS-MÉDICAMENT (CAM) INHIBITEUR DE LA TOPOISOMÉRASE I CIBLANT TROP-2
- German Title of Invention:
- THERAPIE VON KLEINZELLIGEM LUNGENKARZINOM (SCLC) MIT EINEM GEGEN TROP-2 GERICHTETEN TOPOISOMERASE-I-HEMMENDEN ANTIKÖRPER-WIRKSTOFF-KONJUGAT (ADC)
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 10/11/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 16/11/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 11/10/2023
- Unitary Effect Registration Date:
- 16/11/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 21/02/2018
- Grant date:
- 11/10/2023
- EP Publication Date:
- 01/01/2020
- PCT Publication Date:
- 30/08/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 11/10/2023
- EP B1 Publication Date:
- 11/10/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 21/02/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 04/10/2023
- Name:
- Immunomedics, Inc.
- Address:
- 300 American Road, Morris Plains, NJ 07950, United States (US)
Inventor
1
- Name:
- GOVINDAN, Serengulam V.
- Address:
- United States (US)
2
- Name:
- GOLDENBERG, David M.
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201762463316 P
- Priority Date:
- 24/02/2017
- Priority Country:
- United States (US)
2
- Priority Number:
- 201715820708
- Priority Date:
- 22/11/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 47/68; A61K 31/33; C07K 16/30; A61K 31/137; A61K 31/138; A61K 31/255; A61K 31/407; A61K 31/4184; A61K 31/198; A61K 31/513; A61K 31/555; A61K 31/7068; A61K 31/4535; A61K 31/517;
Publication
European Patent Bulletin
1
- Issue number:
- 202341
- Publication date:
- 11/10/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202351
- Publication date:
- 20/12/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202351
- Publication date:
- 20/12/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|